Standaert named chairman of Parkinson Disease Association’s scientific advisory board

Standaert is director of the Center for Neurodegeneration and Experimental Therapeutics and the Division of Movement Disorders in Neurology.

Standaert_David_2011University of Alabama at Birmingham (UAB) School of Medicine Department of Neurology John N. Whitaker Professor and Chair David Standaert, M.D., Ph.D., recently accepted chairmanship of the American Parkinson Disease Association’s (APDA) Scientific Advisory Board.

Standaert is director of the Center for Neurodegeneration and Experimental Therapeutics and the Division of Movement Disorders in Neurology. He also directs UAB’s APDA Advanced Center for Parkinson Research — one of nine APDA-supported centers in major research institutions nationwide — and is medical director of the UAB APDA Information and Referral Center.

As chairman, he directs the 13-member Scientific Advisory Board, which reviews research proposals submitted to the ADPA and advises on strategic issues.

Standaert has been an active member of the APDA advisory board since May 2001, and he is the board’s fourth chairman since the organization’s founding in 1961.

Faculty Excellence

 
 
Back to Top